We are live on ! Find out more
JP Morgan Chase

JP Morgan Chase Portfolio holdings

AUM $1.56T
1-Year Est. Return 27.86%
 

JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.

This Fund
S&P 500
This Quarter Est. Return
+6.67%
1 Year Est. Return
+27.86%
3 Year Est. Return
+90.49%
5 Year Est. Return
+115.47%
10 Year Est. Return
+472.96%
AUM
$475B
AUM Growth
+$21.4B
Cap. Flow
-$8.62B
Cap. Flow %
-1.82%
Top 10 Hldgs %
17.9%
Holding
5,783
New
811
Increased
2,514
Reduced
1,655
Closed
342

Sector Composition

Rank Sector Weight
1 Financials 14.59%
2 Technology 12.2%
3 Healthcare 9.44%
4 Consumer Discretionary 8.6%
5 Industrials 8.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CBUS icon
4651
Cibus
CBUS
$146M
$59K ﹤0.01%
+54
New +$61.2K
TBHC
4652
DELISTED
The Brand House Collective
TBHC
$59K ﹤0.01%
4,883
+3,752
+332% +$45.9K
PACB icon
4653
Pacific Biosciences
PACB
$357M
$59K ﹤0.01%
+22,357
New +$78.3K
SFST icon
4654
Southern First Bancshares
SFST
$594M
$59K ﹤0.01%
+1,425
New +$56.6K
ATNX
4655
DELISTED
Athenex, Inc. Common Stock
ATNX
$59K ﹤0.01%
+187
New +$64K
ELD icon
4656
WisdomTree Emerging Markets Local Debt Fund
ELD
$143M
$58K ﹤0.01%
1,500
GRBK icon
4657
Green Brick Partners
GRBK
$3.03B
$58K ﹤0.01%
+5,128
New +$56.3K
LMNR icon
4658
Limoneira
LMNR
$249M
$58K ﹤0.01%
+2,606
New +$60.4K
PSLV icon
4659
Sprott Physical Silver Trust
PSLV
$13.7B
$58K ﹤0.01%
9,109
-2,105
-19% -$13.2K
LUMO
4660
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
$58K ﹤0.01%
797
+725
+1,007% +$60K
ATTU
4661
DELISTED
Attunity Ltd
ATTU
$58K ﹤0.01%
+8,300
New +$59.7K
TREC
4662
DELISTED
Trecora Resources
TREC
$57K ﹤0.01%
+4,239
New +$53.6K
NEOS
4663
DELISTED
Neos Therapeutics, Inc
NEOS
$57K ﹤0.01%
5,593
-8,156
-59% -$78.3K
NBRV
4664
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
$57K ﹤0.01%
+38
New +$60.1K
AGYS icon
4665
Agilysys
AGYS
$3.02B
$56K ﹤0.01%
4,513
+3,648
+422% +$44.6K
OVID icon
4666
Ovid Therapeutics
OVID
$489M
$56K ﹤0.01%
+5,663
New +$52K
SYT
4667
DELISTED
Syngenta Ag
SYT
$56K ﹤0.01%
604
POT
4668
PUT
DELISTED
Potash Corp Of Saskatchewan
POT
$56K ﹤0.01%
+2,700
New +$52.3K
SNBC
4669
DELISTED
Sun Bancorp Inc
SNBC
$56K ﹤0.01%
+2,323
New +$58.2K
DJCO icon
4670
Daily Journal
DJCO
$773M
$55K ﹤0.01%
+239
New +$56.2K
GNR icon
4671
State Street SPDR S&P Global Natural Resources ETF
GNR
$4.95B
$55K ﹤0.01%
1,131
-150,963
-99% -$7.11M
HONE
4672
DELISTED
HarborOne Bancorp
HONE
$55K ﹤0.01%
+5,110
New +$55K
PRTS icon
4673
CarParts.com
PRTS
$51.2M
$55K ﹤0.01%
+2,184
New +$54.3K
SMBC icon
4674
Southern Missouri Bancorp
SMBC
$842M
$55K ﹤0.01%
+1,465
New +$55.9K
CALA
4675
DELISTED
Calithera Biosciences, Inc
CALA
$55K ﹤0.01%
+330
New +$84.5K

Similar funds

JP Morgan Chase's Q4 2017 Portfolio in Review

As of Q4 2017, JP Morgan Chase held 5,783 positions worth $475B, up 4.7% from $453B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

JP Morgan Chase's Q4 2017 filing shows 811 new, 2,514 increased, 1,655 reduced and 342 closed positions. Its largest new stake was Delphi Technologies PLC Ordinary Shares: 2,961,446 shares worth $155M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $4.01B.

By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 14% a quarter earlier, followed by Technology and Healthcare.

  • JP Morgan Chase's largest Q4 2017 buy was Delphi Technologies PLC Ordinary Shares: 2,961,446 shares worth $155M.
  • JP Morgan Chase added most to Johnson & Johnson in Q4 2017, an estimated $761M increase.
  • JP Morgan Chase's biggest Q4 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $4.01B.
  • JP Morgan Chase fully exited Kite Pharma, Inc. in Q4 2017, selling an estimated $275M.
  • JP Morgan Chase's ten largest holdings make up 18% of its $475B portfolio in Q4 2017.
  • JP Morgan Chase opened 811 new positions and closed 342 in Q4 2017.
  • JP Morgan Chase's portfolio value rose 4.7% quarter-over-quarter to $475B.

Based on JP Morgan Chase's 13F filing for Q4 2017, filed 13 Feb 2018.